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Cell-mediated immunity is a significant aspect of the host response to cytomegalo- 
virus (CMV) infection. We have recently demonstrated that BALB/c mice develop a 
eytotoxic T-lymphocyte (CTL) response to CMV infection (1) and have demonstrated 
that these cells  are distributed through the blood and in infected tissues so that they 
may  contribute  to  the  limitation  of virus  replication  during  the  viremic  stage  of 
infection (2). Other types of effector-cell responses have not been studied, and little is 
known regarding the significance of natural killer (NK) cells or of antibody-dependent 
killer  (K)  cells  in  virus  infections  in  general.  Welsh  and  Zinkernagel  (3)  have 
demonstrated that the cytotoxic lymphocyte responses to lymphocytic choriomenin- 
gitis virus (LCM) are biphasic. The first phase of the CTL response is not genetically 
restricted and apparently not mediated by T  cells. The second phase appears to be a 
typical H-2-restricted CTL response.  A  similar biphasic  response has  been  demon- 
strated  during  Semliki  Forest  virus  infection,  but  the  initial  phase  in  that  case 
appeared to be mediated by maerophages (4). The following studies were performed 
to  determine whether a  similar  phenomenon could be  demonstrated  during CMV 
infection, and to determine the possible significance of this response as a host defense 
mechanism. 
Materials and Methods 
Mice and Cell Cultures.  Pregnant BALB/c and (]3H/HeN mice were obtained from Micro- 
biological Associates, Waikersville, Md. Weanling BALB/c mice were obtained from Charles 
River Breeding Laboratory, Wilmington,  Mass. CBA/n mice were obtained from the Animal 
Production Unit,  National Institutes  of Health,  Bethesda,  Md.  Primary mouse embryo cell 
(ME(]) cultures were prepared as previously described (1). RBL5 cells, a continuous lymphocyte 
line  derived  from  (]57BL/6  mice,  were  provided  by Dr.  J.  Djeu,  Department  of Health, 
Education, and Welfare, Food and Drug Administration,  Bureau  of Biologics, Bethesda,  Md. 
Antiserum for Antibody-dependent Cell-mediated Cytotoxicity (ADCC) Assays.  Anti-(]57BL/6 allo- 
antiserum  was prepared as follows: spleens, thymuses,  and lymph nodes were removed  from 
two adult (]57BL/6 mice, the cells were teased into suspension in 4 ml medium, and 0.5 ml was 
inoculated  s.c. into  each of eight  adult  BALB/c mice. The procedure  was repeated  for six 
weekly injections, the last of which was administered  i.p. 1 wk later, the mice were bled and the 
serum was pooled. 
Viruses.  Weanling mice were inoculated  with  1 X  10' plaque/forming units  (PFU)  of in 
vivo-passaged  Smith strain  murine  cytomegalovirus  (M(]MV)  i.p. (5). ME(] cultures  were 
infected with tissue-culture  passaged MCMV as previously described  (2). Virus titrations  and 
neutralizing-antibody  titrations  were performed  in ME(] cultures  as previously described  (6). 
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Interferon Assays.  Serum specimens from triplicate mice were collected at various times after 
infection and stored at -20°C. Interferon assays were performed by Biofluids, Inc., Rockville, 
Md. Serial 10-fold dilutions of serum were tested for interference of vesicular stomatitis virus 
plaque formation in L929 cells. 
NK-cell  and  ADCC  Assays.  A  microcytotoxicity assay  involving an  18-h  incubation of 
lymphocytes with target  cells similar to that  which we have previously described was used 
throughout (1). The RBL5 cell line has been previously shown to be susceptible to lysis by NK 
cells and, when sensitized by allotypic antisera, to lysis by K cells (7). RBL5 target cells were 
labeled with  [SZCr]sodium chromate  (1)  and resuspended either in diluted heat-inactivated 
BALB/c anti-C57BL/6 serum for ADCC assays, or in media for NK-cell assays. The cells were 
incubated for an additional 30 min at 37°C. Additional media was added to yield a final target 
cell concentration of 1 ×  105 target cells/ml, and 0.1-ml vol were dispersed into wells of plastic 
round-bottomed microtiter plates (Linbro Chemical Co., Hamden Conn.). Pooled spleen cell 
suspensions of triplicate spleens from uninfected CBA/n mice or  from  BALB/c mice were 
prepared in RPMI-1640 (Grand Island Biological Co., Grand Island, N.  Y.)  with 5%  fetal 
bovine serum at various times after infection. Lymphocyte suspensions were washed twice and 
then resuspended, usually at 5  ×  106 cells/ml, and 0.1-ml vol were added to quadruplicate 
wells for test lysis. Suspensions  of unlabeled RBL5 cells, 0.1 ml/well, were added for spontaneous 
lysis; 0.1 mi/well of 10% Brij-35 solution (Sigma Chemical Co., St. Louis, Mo.)  was added for 
maximum lysis determination. 
MCMV-specific  cytotoxic  lymphocyte  assays  were  performed  in  replicates  of  eight  as 
previously described (1). The percentage of specific immune lysis (% SIL) was calculated from 
the equation: 
% SIL =  test lysis -  spontaneous lysis  ×  100. 
maximum lysis -  spontaneous lysis 
Results 
The results of serum neutralizing antibody assays and of plaque assays for titration 
of MCMV  infectivity in spleen cell suspensions and salivary gland homogenates are 
presented in Fig. 1. MCMV titers in spleens reached a maximum within 4 d and then 
gradually decreased to negative within 3 wk. Salivary gland virus titers continued to 
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FIe.  1.  Reciprocal titers of MCMV in spleen cell suspensions and salivary gland homogenates 
and of MCMV neutralizing antibody in serum of BALB/c mice at various times after i.p. inoculation 
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FIG.  2.  Cytotoxic  activity  of  BALB/c  mouse  spleen  ceils  against  syngeneic  uninfected,  an(] 
syngeneic and allogeneic MCMV-infected, MEC at various times after i.p. inoculation of MCMV. 
rise for 2-3 wk after infection,  and then  fell more slowly. Neutralizing  antibody in 
serum was first detected 21 d  after infection. 
No interferon was detected in normal mouse serum. It was first detected on the 2nd 
day after infection,  at  which  time it  had  already reached  maximum levels of 103'1 
U/ml. It then declined over the next 4 d  to undetectable levels. 
The results of cytotoxicity assays using infected and uninfected MEC as target cells 
are presented in Fig.  2.  Specific immune lysis of MCMV-infected BALB/c MEC by 
syngeneic spleen cells was first detected  4  d  after infection,  was highest  ~8 d  after 
infection,  and  returned  to  insignificant  levels by 3-4 wk. There was no significant 
lysis of uninfected BALB/c MEC. Specific immune lysis of MCMV-infected allogeneic 
C3H/HeN  MEC  was detected  from days 3-6 after infection.  The results indicated 
that  the initial  virus-specific cytotoxicity was not genetically restricted, whereas the 
later activity was restricted. 
Results  of assays of spleen  cells  for  NK-  and  K-cell  activity  indicated  that  the 
optimum incubation time was 18 h, because the % SIL was greatest at that time, and 
spontaneous lysis was only 20-30% of maximum lysis. Experiments were performed to 
determine the optimum effector:target ratio and to determine the maximum useful 
dilution of the BALB/c anti-C57BL/6 serum used to sensitize target cells for ADCC 
assays. Results of two of these experiments are presented in Table I. Similar results 
were  obtained  using  spleen  cells  from  uninfected  CBA/n  mice  or  from  BALB/c 
mice 3  d  after infection.  Cytotoxic cells were not  detected  in  spleens of uninfected 
BALB/c mice using these assays (results not shown). In subsequent experiments, the 
antiserum was routinely used at a dilution of 1:100.  The optimum effector:target ratio 
was found to be 50:1; at higher ratios, spontaneous target cell lysis sometimes increased 
to unacceptable levels. Under these conditions greater % SIL was routinely measured 
in the ADCC assay than in the NK-cell assay. 
The  changes  in  activity  in  response  to  infection  of the  cytotoxic  lymphocytes 
measured  by  these  two  assays  are  shown  in  Fig.  3.  CMV-infeeted  BALB/c  mice 
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TABLE  I 
Assay For NK and K Cells: Determination of Optimum Serum Concentration and Optimum Effector:  Target 
Ratio 
Effector:target ratio 
RBL5 cells 
% SIL 
RBL5 cells sensitized with anti-C57BL/6 se- 
rum diluted: 
1:100  1:500 
BALB/c* 
200:1  9.0  31.9  31.1 
50:1  22.2  42.2  58.8 
20:1  0.0  12.1  3.2 
CBA/n* 
200:1  0.0  17.8  3.2 
50:1  7.4  26,9  17.7 
20:1  0.0  12.4  3.2 
* BALB/c spleens removed 3 d after i.p, infection with 1 X  104 PFU of MCMV. 
* CBA/n spleens removed from uninfected 6-wk-old mice. 
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FIG.  3.  Cytotoxic activity of spleen lymphocytes of BALB/c  mice against RBL5 cells and RBL5 
cells sensitized with  antibody to C57BL/6  alloantigens at  various times alter  i.p.  inoculation  of 
MCMV. 
TABLE II 
Effect of Pretreatment of Spleen Cell Suspensions on NK- and K-Cell Activity 
Treatment* 
% SII~ 
RBL5 target cells  C57BL/6-RBL5 target cells 
None  20.4  30.2 
Nylon-wool pass,aged  17.9  25.6 
Anti-theta serum +  C'§  14.5  18.7 
C'  20.2  24.0 
Media control  25.4  28.3 
* Spleens removed from BALB/c mice 3 d after i.p. inoculation of 1 ×  104 PFU of MCMV. 
* Results are mean values from two experiments. 
§ C', complement. 
and persisting through day 5 or 6 after i.p. virus inoculation. 
The  results  of experiments  performed  to  determine  the cell  type  responsible  for 
target cell lysis in the NK- and K-cell assays are presented  in Table II.  Nylon-wool 
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suspensions. Lysis ofT lymphocytes in suspensions by treatment with anti-theta serum 
and complement also failed to significantly affect the activity of the cytotoxic effector 
cells. These results indicated that the predominant cytotoxic cell type(s) detected in 
each of these two assays were not macrophages or B or T  lymphocytes. 
Discussion 
Cell-mediated immune lysis of herpes virus-infected cells is potentially important 
as a  host defense mechanism by which infected cells may be destroyed before virus 
replication has occurred. Although much attention has been given to the frequency 
of severe and fatal CMV infections in individuals with depressed cellular immunity 
(8),  little  is  known  about  specific  functions  of different  types  of effector cells  as 
mediators of resistance to these infections. We have previously defined a CTL response 
to  MCMV  infection  (1).  This  CTL  response  is  virus-specific,  H-2-restricted,  and 
correlates temporally with the viremic phase of infection. During this time, CTL are 
distributed  through  the  peripheral  blood and  in  cervical lymph  nodes  (2).  These 
earlier findings suggest that CTL may contribute significantly to the immune control 
of the acute, viremic phase of infection. 
The studies reported here demonstrate that spleen lymphocytes develop the capac- 
ity, during days 3-6 after i.p. inoculation of MCMV, to lyse syngeneic and allogeneic 
MCMV-infected target cells. CTL responses to a number of virus infections have been 
described (1-4, 9). In each case, these CTL have been found to be H-2 restricted. The 
initial phase of the cytotoxic lymphocyte response to MCMV infection is, therefore, 
probably not mediated by CTL, whereas the second phase has been previously shown 
to be mediated by T  lymphocytes (1). A biphasic response with similar characteristics 
has also been found during murine LCM infection (3), indicating that the pattern of 
response measured here is not unique to one virus. 
Activity of NK  and  K  cells was  found to be  increased  between  days  3-6  after 
infection. In each assay system, the cytotoxic lymphocytes possessed characteristics 
typical of NK and K  cells (10).  They were nonadherent, and lacked theta antigen. 
Because  these  assays  did  not  involve the  use  of MCMV-infected  target  cells,  the 
cytotoxicity measured was clearly not dependent on virus-specific antibody, nor the 
presence of viral antigens on the surface of the target cells. However, the simultaneous 
occurrence of this response and the first phase of the virus-specific cytotoxic lympho- 
cyte response suggests that the same effector cell(s) may have been involved. 
The  mechanism  by which  NK or  K  cells could  specifically recognize MCMV- 
infected cells  is  unknown.  We  cannot  completely exclude the  possibility  that  the 
cytotoxic effect of these  cells  was  antibody  dependent,  but  we  could  not  detect 
neutralizing antibody in serum until 2 wk after this cytotoxic-cell response had abated. 
It is possible that  MCMV  infection induced the formation of nonviral antigens on 
infected cells which reacted specifically or by cross-reaction with antigens to which 
the animal was previously exposed. Regarding this possibility, it has been shown by 
Boyd et  al.  (11),  that  infection of cells with  a  variety of herpes viruses,  including 
CMV,  results in activation of endogenous type C  viruses. Antigens of these viruses 
might be recognized by naturally occurring or preexisting antibody and thus provide 
specific recognition sites for NK or K cells. Alternatively, virus infection might result 
in differentiation of a  subset of NK cells capable of specific recognition of MCMV 
antigens in the absence of antibody. 
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probably serve an important  role early in the course of MCMV  infection.  It is likely 
that these effector cell functions are stimulated by virus-induced interferon, and may 
then  specifically  recognize  and  lyse  syngeneic  or  allogeneic  MCMV-infected  cells. 
This broadly reactive response is then replaced within 3-4 d, and as serum interferon 
levels fall, by the highly specific, genetically restricted CTL response. Thus, NK and 
K  cells may contribute  to the role of CTL in controlling the acute, viremic phase of 
MCMV  infection. 
Summary 
Definition  of the  functions  by which  the  cellular  immune  system  contributes  to 
control  of cytomegalovirus  (CMV)  infection  should  permit  determination  of the 
specific defects which result in the increased susceptibility to infection of immunosup- 
pressed  individuals.  Using  a  murine  model,  we  studied  the  cytotoxic  lymphocyte 
response  to  murine  CMV  infection.  This  response  was  found  to  be  biphasic.  The 
initial  phase extended  from the 3rd to the 6th d  after infection, was not genetically 
restricted,  and correlated  to a  rise in numbers of natural  killer  (NK)  and antibody- 
dependent killer (K) cells in spleens. The NK- and K-cell responses were preceded, by 
24 h, by a rise in serum interferon levels, and occurred before the time when antibody 
could be measured in serum by neutralization.  NK and K  cells appear to develop the 
capacity for specific recognition of CMV-infected cells and the potential to contribute 
to control of the acute phase of CMV infection. 
Received  for publication  13 August  1979. 
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